Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:7 Issue:9 Number:26 ISSN#:2564-2537
ACE Report #10378
Ace Report Cover Cannabis

Nabilone safe and effective in pain reduction in combination with gabapentin compared to placebo

How to Cite

OrthoEvidence. Nabilone safe and effective in pain reduction in combination with gabapentin compared to placebo. ACE Report. 2018;7(9):26. Available from: https://myorthoevidence.com/AceReport/Report/10378

Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Nabilone as an adjunctive to gabapentin for multiple sclerosis-induced neuropathic pain: a randomized controlled trial

Pain Med. 2015 Jan;16(1):149-59. doi: 10.1111/pme.12569

Contributing Authors: D Turcotte M Doupe M Torabi A Gomori K Ethans F Esfahani K Galloway M Namaka

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


Current convention in managing neuropathic pain (NPP) from relapsing-remitting multiple sclerosis (RRMS) often involves gabapentin (GBP) as first-line therapy and cannabis (CB) as an alternative, had other therapies not worked. The combination of GBP and CB has not been explored. In this study, 15 patients with NPP from RRMS and still experience considerable pain after a stable dosage of GBP were ...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

For Reprints and Permissions, click here

Please Login or Join to leave comments.